Adrenoleukodystrophy differential diagnosis: Difference between revisions
Ibtisamshrf (talk | contribs) |
Ibtisamshrf (talk | contribs) |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Adrenoleukodystrophy must be differentiated from | Adrenoleukodystrophy must be differentiated from [[Leigh syndrome]], [[Niemann-Pick]] disease type C, Infantile Refsum disease, [[Zellweger syndrome]], [[Pyruvate dehydrogenase deficiency]], [[Arginase deficiency]], Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, [[Ataxia telangiectasia]], [[Pontocerebellar]] [[hypoplasias]], [[Metachromatic leukodystrophy]], [[Pelizaeus-Merzbacher]], [[Angelman syndrome]], [[Rett syndrome]], [[Lesch-Nyhan syndrome]], Miller-Dieker lissencephaly and Dopa-responsive [[dystonia]]. | ||
==Differential Diagnosis== | ==Differential Diagnosis== |
Latest revision as of 18:50, 23 June 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Adrenoleukodystrophy must be differentiated from Leigh syndrome, Niemann-Pick disease type C, Infantile Refsum disease, Zellweger syndrome, Pyruvate dehydrogenase deficiency, Arginase deficiency, Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, Ataxia telangiectasia, Pontocerebellar hypoplasias, Metachromatic leukodystrophy, Pelizaeus-Merzbacher, Angelman syndrome, Rett syndrome, Lesch-Nyhan syndrome, Miller-Dieker lissencephaly and Dopa-responsive dystonia.
Differential Diagnosis
Adrenoleukodystrophy must be differentiated from other diseases that cause neurological manifestations in infants.
Diseases | Type of motor abnormality | Clinical findings | Laboratory findings and diagnostic tests | Radiographic findings | |||
---|---|---|---|---|---|---|---|
Spasticity | Hypotonia | Ataxia | Dystonia | ||||
Leigh syndrome | - | - | + | + |
|
| |
Niemann-Pick disease type C | - | - | + | + |
|
|
|
Infantile Refsum disease | - | + | + | - |
|
Elevated plasma VLCFA levels | -- |
Adrenoleukodystrophy | + | - | - | - |
|
|
-- |
Zellweger syndrome | - | + | - | - |
|
|
-- |
Pyruvate dehydrogenase deficiency | + | + | + | - | -- | ||
Arginase deficiency | + | - | - | - | -- | ||
Holocarboxylase synthetase deficiency | - | + | - | - | Elevated levels of:
|
-- | |
Glutaric aciduria type 1 | - | - | - | + |
|
Elevated levels of:
|
|
Ataxia telangiectasia | - | - | + | - |
|
|
-- |
Pontocerebellar hypoplasias | - | + | - | - |
|
Genetic testing for PCH gene mutations |
|
Metachromatic leukodystrophy | - | + | + | - |
|
|
-- |
Pelizaeus-Merzbacher | + | - | + | - |
|
| |
Angelman syndrome | - | - | + | - |
|
|
-- |
Rett syndrome | + | - | - | + |
|
-- | |
Lesch-Nyhan syndrome | + | - | - | + |
|
-- | |
Miller-Dieker lissencephaly | + | + | - | - |
|
|
-- |
Dopa-responsive dystonia | + | - | - | + |
|
|
-- |